KYTHERA Biopharmaceuticals, which is commercializing an injectable treatment for double chins with Bayer, raised $70 million by offering 4.4 million shares at $16, at high end of the range
The fourth quarter got off to an active start this week as six of seven deals on the calendar priced. The trend of pricing pressure continued in October’s first week as four of
SolarCity, which provides solar power system design, financing, installation and monitoring services, filed on Friday with the SEC to raise up to $201 million in an initial public offering.